News Articles and Montana BioScience Alliance Newsletters
TNX-4300’s Mechanism of Restoring Neuroplasticity Supports Development as a First-in-Class Oral Therapy for Depression, Bipolar Disorder, Alzheimer’s Disease and Parkinson’s Disease
Extends patent protection for Microbion’s proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039.
News, events, and SBIR/STTR Solicitations for May
A scientific team that includes University of Montana biologist Mark Grimes recently used artificial intelligence to better understand how protein groups in lung cancer cells regulate cell division and metabolism. The work may lead to greater understanding of lung cancer vulnerabilities and future anti-cancer therapies.
Viral clearance testing is a critical step in the development and production of biologics and other products that are derived from biological sources. GMP-compliant service provides the assurance that products have been thoroughly tested for the presence of viral contaminants, and that they are safe for use.
Biomarker testing helps connect patients with the most effective treatments for their cancer – but not all patients are benefiting from the latest advances in cancer treatment. Learn how biomarker testing helps cancer patients and what can be done to improve access and advance health equity.
Bio event draws about 3,000 companies to the San Diego Convention Center to take stock of the latest trends and research.
Four-time gold medalist and seven-time Grand Slam singles champion Venus Williams will discuss her groundbreaking career, business success, and prioritizing health in a conversation moderated by Emmy-nominated sports reporter Erin Andrews at the BIO International Convention June 13-16, 2022, in San Diego. Both women have faced their own health challenges, becoming advocates for increased awareness and better outcomes for all.
As the pandemic enters its third year, long Covid has emerged as an increasingly important concern. And many people are wondering whether getting a Covid shot can reduce their chances of developing long-term symptoms.
Congress has returned to Capitol Hill, and among the most important unfinished business on its agenda is agreeing to a new package to fight COVID-19 by funding second-generation vaccine research. When Congress left town, there was cautious optimism that a deal was close.
View the Spring 2023 Newsletter now!
View the Winter 2022 Newsletter now!